Pregled bibliografske jedinice broj: 1257159
Less invasive left ventricular assist device implantation is safe and feasible in patients with smaller body surface area
Less invasive left ventricular assist device implantation is safe and feasible in patients with smaller body surface area // The journal of heart and lung transplantation, 41(2022), 4
Boston (MA), Sjedinjene Američke Države, 2022. str. S135-S135 doi:10.1016/j.healun.2022.01.317 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1257159 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Less invasive left ventricular assist device implantation is safe and feasible in
patients with smaller body surface area
(Less invasive left ventricular assist device
implantation is safe and feasible in patients with
smaller body surface area)
Autori
Wood, K.L. ; Bjelić, M. ; Paić, Frane ; Vidula, H. ; Cheyne, C. ; Chase, K. ; Bernstein, W. ; Wyrobek, J.A. ; Alexis, J.D. ; Gosev, I.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
The journal of heart and lung transplantation, 41(2022), 4
/ - , 2022, S135-S135
Skup
Less invasive left ventricular assist device implantation is safe and feasible in patients with smaller body surface area
Mjesto i datum
Boston (MA), Sjedinjene Američke Države, 27.04.2022. - 30.04.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
LVAD ; BSA
Sažetak
Purpose: Smaller body surface area (BSA) frequently precludes patients for Left Ventricular Assist Device (LVAD) therapy. We sought to investi- gate the clinical outcomes in patients with small BSA undergoing less invasive LVAD implantation. Methods: We conducted a retrospective review of 216 patients implanted with HeartMate 3 LVAD via less invasive surgery (LIS) at our institution. Patients were dichotomized and compared based on their pre- implant BSA: small BSA (BSA≤1.8 m2) and normal/large BSA (BSA>1.8 m2). We analyzed patients’ perioperative characteris- tics and outcomes. Results: In our study, small BSA was found in 32 (14.8%) patients, while 184 (85.2%) had normal/large BSA (Table 1). Women were more preva- lent in the small BSA group (50.0% vs. 13.0%, p<0.001). Preoperative and intraoperative data showed comparable results. Major complications and hospital length of stay did not differ by BSA group. Patients with smaller BSAs had significantly decreased pump parameters at discharge, this includes LVAD flow (4.11§0.49 vs.4.60§0.54, L/min, p<0.001) and pump speed (5200 vs. 5400, rpm, p<0.001). Survival to discharge and within 6 post- implantation months were similar between the groups (Figure 1). Conclusion: Our study results suggest that less invasive HeartMate 3 implantation can be safely performed and demonstrates equivalent out- comes in patients with smaller body habitus. Randomized trials are required to confirm our data.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE